Zaprinast, a phosphodiesterase type-5 inhibitor, alters paced mating behavior in female rats.
Nitric oxide (NO) is the primary mediator of blood flow in female genital tissues and drugs that enhance the activity of nitric oxide, such as phosphodiesterase type-5 (PDE-5) inhibitors, increase vaginal blood flow in anesthetized rats. The goal of the present study was to test the effects of one PDE-5 inhibitor, zaprinast, on the display of sexual behaviors in gonadectomized, estrogen- and progesterone-treated female rats. Experiment 1 demonstrates that zaprinast alters paced mating behavior by lengthening the contact-return latency to ejaculation; there is a significant relationship between dose of zaprinast (range 1.5-6 mg/kg) and contact-return latency to ejaculation. Experiment 2 illustrates that zaprinast has no effect on preference for an intact male as measured in a No Contact partner preference test. Rats receiving zaprinast tend to exhibit reduced locomotor activity in both experiments. Collectively, these findings demonstrate that modulation of the NO-cGMP pathway using a PDE-5 inhibitor alters the display of paced mating behaviors in rats.
Clark
Ann S
AS
Department of Psychological and Brain Sciences, Dartmouth College, Hanover NH 03755, USA. ann.s.clark@dartmouth.edu
Meerts
Sarah H
SH
Guarraci
Fay A
FA
D000818:Animals; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D008297:Male; D052586:Mating Preference, Animal / Q000187:drug effects; D020714:Maximum Tolerated Dose; D010052:Ovariectomy / Q000379:methods; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D011374:Progesterone / Q000494:pharmacology; D011372:Progestins / Q000494:pharmacology; D011688:Purinones / Q000494:pharmacology*; D051381:Rats; D020318:Rats, Long-Evans; D011930:Reaction Time / Q000187:drug effects; D012726:Sexual Behavior, Animal / Q000187:drug effects*; D013997:Time Factors
D004967:Estrogens; D010726:Phosphodiesterase Inhibitors; D011372:Progestins; D011688:Purinones; D011374:Progesterone; C011145:zaprinast